Culture

Sound waves spin droplets to concentrate, separate nanoparticles

video: Duke University researchers are concentrating and separating tiny particles by spinning individual droplets of liquid with soundwaves.

Image: 
Ken Kingery, Duke University

DURHAM, N.C. - Mechanical engineers at Duke University have devised a method for spinning individual droplets of liquid to concentrate and separate nanoparticles for biomedical purposes. The technique is much more efficient than traditional centrifuge approaches, working its magic in under a minute instead of taking hours or days, and requires only a tiny fraction of the typical sample size. The invention could underline new approaches to applications ranging from precision bioassays to cancer diagnosis.

The results appear online on December 18 in the journal Science Advances.

"This idea originated from a very exciting recent finding that you can use surface acoustic waves to spin a droplet of liquid," said Tony Jun Huang, the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke. "We decided to investigate whether we could use this method to create a point-of-care system that can separate and enrich nanoparticles quickly and efficiently."

Huang and his doctoral student Yuyang Gu began their investigation by building a device capable of spinning individual droplets of liquid. In the center of a piezoelectric surface sits a ring of polydimethylsiloxane, a type of silicon commonly used in microfluidic technologies, which confines the droplet's boundaries and keeps it in place. The researchers then placed a sound wave generator called a interdigitated transducer (IDT) on each side and slanted them so that sound waves with different frequencies travel through the piezoelectric surface to enter the droplet.

When turned on, the IDTs create surface acoustic waves that push on the sides of the droplets like Donald Duck getting blown over by a gigantic pair of speakers. At low power settings, the top of the droplet begins to wobble around the ring like a muffin top made of Jell-O. But when the power gets turned up to 11, the balance between the surface tension of the droplet and its centrifugal force causes it to take on the shape of a pill and begin spinning in place.

The researchers then investigated how fluorescent nanoparticles of different sizes behaved within the spinning droplets. Because the droplet is spinning, the nanoparticles themselves also got dragged along in a helical pattern. Depending on their size and the frequency of sound, they were also pushed toward the center of the droplet due to the incoming force of the sound waves and hydrodynamics.

The researchers found that by using different frequencies, they could specifically concentrate particles as small as tens of nanometers. These sizes correlate to biologically important molecules such as DNA and exosomes -- biological nanoparticles released from every type of cell in the body that are thought to play an important role in cell-to-cell communication and disease transmission.

But they were still faced with another problem. While nanoparticles of one size flocked to the center of the droplet, nanoparticles of other sizes were still flying randomly about, making it difficult to access the concentrated bounty.

Their solution? A second spinning droplet.

"We set up two droplets of different sizes next to each other so that they'd be spinning at different speeds," said Gu. "By connecting them with a small channel, any nanoparticles not concentrating in the first end up spinning off and getting trapped in the second."

To further show how useful their dual-droplet centrifugal system could be, the researchers showed that it could successfully separate subpopulations of exosomes from a sample. And unlike common centrifugation methods that require large amount of samples and can take overnight to work, their solution only needed a much smaller sample volume--such as five microliters--and less than a minute.

"We envision this work simplifying and speeding up sample processing, detection and reagent reactions in various applications such as point-of-care diagnostics, bioassays and liquid biopsies," said Gu.

"The ability to separate and enrich exosome subpopulations and other biological nanoparticles is extremely important." added Huang. "For example, while the recent discovery of exosome subpopulations has excited biologists and researchers due to their potential to revolutionize the field of non-invasive diagnostics, exosome sub-populations have yet to be utilized in clinical settings. This is largely due to the difficulties associated with separating exosome subpopulations because of their small size. Our approach offers a simple, automated approach for separating exosome sub-populations in a fast and biocompatible manner. As a result, we believe that it is critical to unlocking the clinical utility of exosome subpopulations."

Credit: 
Duke University

Stroke and altered mental state increase risk of death for COVID-19 patients

December 18, 2020--(BRONX, NY)--People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients, according to a study published online today by researchers at Montefiore Health System and Albert Einstein College of Medicine in the journal Neurology®, the medical journal of the American Academy of Neurology. These findings have the potential to identify and focus treatment efforts on individuals most at risk and could decrease COVID-19 deaths.

The study looked at data from 4,711 COVID-19 patients who were admitted to Montefiore during the six-week period between March 1, 2020 and April 16, 2020. Of those patients, 581 (12%) had neurological problems serious enough to warrant brain imaging. These individuals were compared with 1,743 non-neurological COVID-19 patients of similar age and disease severity who were admitted during the same period.

"This study is the first to show that the presence of neurological symptoms, particularly stroke and confused or altered thinking, may indicate a more serious course of illness, even when pulmonary problems aren't severe," said David Altschul, M.D., chief of the division of neurovascular surgery at Einstein and Montefiore and associate professor in the Leo M. Davidoff Department of Neurological Surgery and of radiology at Einstein. "Hospitals can use this knowledge to prioritize treatment and, hopefully, save more lives during this pandemic."

Among people who underwent brain imaging, 55 were diagnosed with stroke and 258 people exhibited confusion or altered thinking ability. Individuals with stroke were twice as likely to die (49% mortality) compared with their matched controls (24% mortality)--a statistically significant difference. People with confusion had a 40% mortality rate compared with 33% for their matched controls--also statistically significant.

More than half the stroke patients in the study did not have hypertension or other underlying risk factors for stroke. "This highly unusual finding agrees with other studies of people with COVID-19 in suggesting that infection with the novel coronavirus is itself a risk factor for stroke," said Dr. Altschul, who is also surgical director of the Montefiore Comprehensive Center for Stroke Care, and the study co- author, along with Emad Eskandar, M.D., M.B.A., chair of neurological surgery at Einstein and Montefiore, professor in the Leo M. Davidoff Department of Neurological Surgery, the department of psychiatry and behavioral sciences, in the Dominick P. Purpura Department of Neuroscience at Einstein. Dr. Eskandar also holds the Jeffrey P. Bergstein Chair and the David B. Keidan Chair in Neurological Surgery.

Credit: 
Albert Einstein College of Medicine

Experts call for Europe-wide COVID-19 targets

A group of more than 300 leading scientists across the globe are calling for European governments to work together in managing the pandemic and make a clear commitment to COVID-19 case number targets.

The letter, co-authored by Dr Deepti Gurdasani from Queen Mary University of London and coordinated by Viola Priesemann from the Max Planck Institute for Dynamics and Self-Organization in Göttingen, is published today in The Lancet.

"Across Europe, the COVID-19 pandemic is causing excess deaths, placing a burden on societies and health systems, and harming the economy," they write. "Yet European governments have yet to develop a common vision to guide the management of the pandemic."

The letter outlines the need for a pan-European commitment to reducing and maintaining case numbers for COVID-19 at very low levels to protect people's health, society and economies. It highlights how uncontrolled spread in one region can put the successful management of the pandemic in other regions at risk, suggesting a common vision is needed to achieve this goal.

"With open borders across Europe, a single country alone cannot keep the number of COVID-19 cases low; thus joint action and common goals among countries are essential," the authors write. "We therefore call for a strong, coordinated European response and clearly defined goals for the medium and long term."

To better manage the COVID-19 pandemic, the scientists are proposing a strategy with three core elements:

1) Achieve low case numbers - aiming for a target of no more than ten new COVID-19 cases per million people per day, with synchronisation across all European countries so that SARS-CoV-2 infections are not imported across borders.

2) Keep case numbers low - with continued and improved mitigation measures (such as mask wearing, hygiene, moderate contact reduction, testing and contact tracing), a strategy for delivering at least 300 tests per million people per day, and rapid response to local outbreaks.

3) Develop a longer-term common vision - with context-sensitive regional and national action plans as well as European level goals, strategies for elimination, screening, vaccination, protection of those at high risk, and support for those most affected by the pandemic.

The authors conclude: "We urge governments throughout Europe to agree on clearly formulated common goals, to coordinate their efforts, to develop regionally adapted strategies to reach the goals, and thereby work resolutely towards low case numbers."

Credit: 
Queen Mary University of London

APS plays foundational role in development of COVID-19 vaccines

image: Data taken at the APS shows the neutralizing antibody D25 binding to the F protein of the Respiratory Syncytial Virus (RSV). This binding stabilizes the protein in its prefusion form. Several COVID-19 vaccines include similar mutations that stabilize spike proteins in their more vulnerable form.

Image: 
Jason McLellan

There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one — developed by Pfizer/BioNTech — already having been approved for emergency use in the United States. This has been the fastest development and rollout of any vaccine in history, starting with the first gene sequence released in January. (The previous record was held by the mumps vaccine, which took four years.)

“There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with two — developed by Pfizer/BioNTech and Moderna — already having been approved for emergency use in the United States.” Case in point: five of the vaccines, including those developed by Pfizer/BioNTech and Moderna, contain genetic mutations that increase their effectiveness, mutations based upon work dating back more than 10 years using the resources of the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory.

“The previous work allowed us to move very quickly. Vaccine development usually takes a decade. The RSV vaccine we created in 2013 is just now entering phase 3 clinical trials. COVID-19 went from a genome sequence to first immunization in less than a year.” — Jason McLellan, University of Texas at Austin

The APS has been at the forefront of the field of structural biology since its ultrabright X-ray beams first started shining in 1995. Scientists use those powerful beams of light to illuminate the structures of viruses, producing detailed pictures of the makeup of their proteins. Those pictures are then used to design techniques, drugs and vaccines that fight the virus more effectively.

Which is exactly what these mutations do. They were developed by Jason McLellan, now an associate professor at the University of Texas at Austin, and Barney Graham, currently the deputy director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH). The pair’s current work on COVID-19 vaccines was heavily influenced by their research into an entirely different disease: respiratory syncytial virus (RSV), which affects thousands per year.

“We started that work in 2009,” said McLellan, who was then a postdoctoral researcher in Peter Kwong’s lab at NIH. “It took a while, but we had success developing a vaccine candidate for RSV in 2013.”

The key to that vaccine, which is now entering phase 3 trials, was a better understanding of one of the virus’s proteins. The F protein in RSV adorns the surface of the virus and makes first contact with human cells, infecting them. This protein has two shapes: prefusion, a smaller mushroom-like form that first makes contact with cells, and postfusion, an extended form that initiates entry of the virus into those cells. Once the protein is in its postfusion shape, infection has begun, and it is more difficult for the immune system to fight the virus off.

McLellan and Graham worked on the theory that a vaccine directed at the F protein in its prefusion mode should be more effective. They created more than 100 different variants of that protein to find a version that they could stabilize in the prefusion form. This would provide a target for the immune system, helping it to develop neutralizing antibodies against the virus. Parts of that work were done at the Southeast Regional Collaborative Access Team (SER-CAT) beamline at the APS, operated by the University of Georgia.

In May 2013, the pair and their colleagues reported success, publishing their work in Science. In November 2013, they reported a vaccine candidate for RSV that neutralized the F protein, stabilizing it in its prefusion form. That paper was also published in Science, and included structural work performed at SER-CAT. In 2019 McLellan, Graham and their colleagues published the clinical proof-of-concept in Science that showed the prefusion molecule was a better vaccine antigen.

McLellan and Graham soon learned that the technique they discovered could be applied to coronaviruses.

“Barney and I started thinking about what to look at next, and coronaviruses in general were similar to RSV,” McLellan said. “Both contain a similar protein: the spike in coronaviruses is like the F protein in RSV, except that the spike is about two and a half times the size. It’s like the F protein on steroids.”

In 2013, McLellan and his colleagues, including Nianshuang Wang, now at Regeneron Pharmaceuticals, began working with Graham and his NIH colleague Kizzmekia Corbett on a vaccine for the Middle East Respiratory Syndrome coronavirus (MERS-CoV). The team applied the same technique to MERS-CoV, and in 2017 reported similar success. This time they performed some of their work at the Structural Biology Center (SBC) at the APS, and published results in the Proceedings of the National Academy of Sciences.

“Both McLellan and Graham are longtime users of the APS, and their work to understand RSV and MERS-CoV led to an effective technique to neutralize both viruses,” said Argonne’s Bob Fischetti, group leader and life sciences advisor to the APS director. “The structural work performed at the APS played a key role in the discovery of this technique, and we are now seeing how important it might be.”

When SARS-CoV-2 emerged, McLellan, Wang and graduate student Daniel Wrapp, now at the University of Texas at Austin, joined with Graham and Corbett to see if the same technique would work to inhibit this new virus's spread. And once they were able to examine the structure of the spike protein, they discovered that it did.

“Being able to solve the structure of the SARS-CoV-2 spike protein and know that it was in the desired conformation within three weeks of sequence release was critical for rapidly advancing vaccine development and antibody discovery programs,” Graham said.

The initial results of their work, a mutation called S-2P, is now in SARS-CoV-2 vaccines developed by Moderna, Pfizer/BioNTech, Novavax, Johnson & Johnson and CureVac, McLellan confirmed. Pfizer’s and Moderna’s vaccines use messenger RNA (mRNA) to instruct human cells to make the mutant of the spike protein that the immune system then develops antibodies against. If a person is infected with the virus, the immune system then recognizes it before infection and the antibodies neutralize the spike protein, by binding to it and preventing it from infecting the cell.

“The U.S. Food and Drug Administration granted an emergency use authorization for Pfizer’s vaccine on Dec. 12, and did the same for Moderna’s vaccine on Dec. 18. Both vaccines are now being administered in the United States.”

“The previous work allowed us to move very quickly,” McLellan said. “Vaccine development usually takes a decade. The RSV vaccine we created in 2013 is just now entering phase 3 clinical trials. COVID-19 went from a genome sequence to first immunization in less than a year. We played a role in the development of the antigen. There was a massive response to this coronavirus. Lots of labs and companies contributed.”

McLellan and his colleagues published further work on SARS-CoV-2 in Science in September. Again the scientists tested more than 100 variations of the spike protein, this time using a technique called cryogenic electron microscopy at their own labs. They ended up with a molecule called HexaPro that could be 10 times as potent as the S-2P spike protein in the current COVID-19 vaccines. It is currently being evaluated for use by several companies.

While the prospect of several COVID-19 vaccines is exciting, McLellan is similarly heartened by what this accelerated development process means for the future. We don’t know what the next pathogens are going to be, he notes, and the tools and techniques being developed now will play an important role.

“We have learned a lot about the different steps involved in a pandemic response,” he said. “The vaccine development platform will continue to mature. The speed and new technology saves us days and weeks, and helps with the game plan to respond to future pandemics.”

Graham and Corbett were recently named recipients of a Golden Goose Award for their work on COVID-19 research, and McLellan’s work is recognized in the announcement.

The APS has dedicated more than 10,000 hours of time to research into the structure of SARS-CoV-2 this year, and has made its resources available to more than 80 groups of researchers from across the country, in addition to the work done by Argonne scientists there. With more than 100 structures of the virus made available to the world scientific community — more than any other U.S. light source — the APS has been an important factor in the effort to combat COVID-19.

“Just as what we learned from previous outbreaks helped to create vaccines and treatments at record speed, what we are learning about SARS-CoV-2 at the APS will help fight not only this outbreak, but future ones,” said Stephen Streiffer, Argonne’s deputy laboratory director for science and technology and the interim director of the APS.

Credit: 
DOE/Argonne National Laboratory

Land ecosystems are becoming less efficient at absorbing CO2

Land ecosystems currently play a key role in mitigating climate change. The more carbon dioxide (CO2) plants and trees absorb during photosynthesis, the process they use to make food, the less CO2 remains trapped in the atmosphere where it can cause temperatures to rise. But scientists have identified an unsettling trend - as levels of CO2 in the atmosphere increase, 86 percent of land ecosystems globally are becoming progressively less efficient at absorbing it.

Because CO2 is a main 'ingredient' that plants need to grow, elevated concentrations of it cause an increase in photosynthesis, and consequently, plant growth - a phenomenon aptly referred to as the CO2 fertilization effect, or CFE. CFE is considered a key factor in the response of vegetation to rising atmospheric CO2 as well as an important mechanism for removing this potent greenhouse gas from our atmosphere - but that may be changing.

For a new study published Dec. 10 in Science, researchers analyzed multiple field, satellite-derived and model-based datasets to better understand what effect increasing levels of CO2 may be having on CFE. Their findings have important implications for the role plants can be expected to play in offsetting climate change in the years to come.

"In this study, by analyzing the best available long-term data from remote sensing and state-of-the-art land-surface models, we have found that since 1982, the global average CFE has decreased steadily from 21 percent to 12 percent per 100 ppm of CO2 in the atmosphere," said Ben Poulter, study co-author and scientist at NASA's Goddard Space Flight Center. "In other words, terrestrial ecosystems are becoming less reliable as a temporary climate change mitigator."

What's Causing It?

Without this feedback between photosynthesis and elevated atmospheric CO2, Poulter said we would have seen climate change occurring at a much more rapid rate. But scientists have been concerned about how long the CO2 Fertilization Effect could be sustained before other limitations on plant growth kick in.

For instance, while an abundance of CO2 won't limit growth, a lack of water, nutrients, or sunlight - the other necessary components of photosynthesis -- will. To determine why the CFE has been decreasing, the study team took the availability of these other elements into account.

"According to our data, what appears to be happening is that there's both a moisture limitation as well as a nutrient limitation coming into play," Poulter said. "In the tropics, there's often just not enough nitrogen or phosphorus, to sustain photosynthesis, and in the high-latitude temperate and boreal regions, soil moisture is now more limiting than air temperature because of recent warming."

In effect, climate change is weakening plants' ability to mitigate further climate change over large areas of the planet.

Next Steps

The international science team found that when remote-sensing observations were taken into account - including vegetation index data from NASA's Advanced Very High Resolution Radiometer (AVHRR) and the Moderate Resolution Imaging Spectroradiometer (MODIS) instruments - the decline in CFE is more substantial than current land-surface models have shown. Poulter says this is because modelers have struggled to account for nutrient feedbacks and soil moisture limitations - due, in part, to a lack of global observations of them.

"By combining decades of remote sensing data like we have done here, we're able to see these limitations on plant growth. As such, the study shows a clear way forward for model development, especially with new remote sensing observations of vegetation traits expected in coming years," he said. "These observations will help advance models to incorporate ecosystem processes, climate and CO2 feedbacks more realistically."

The results of the study also highlight the importance of the role of ecosystems in the global carbon cycle. According to Poulter, going forward, the decreasing carbon-uptake efficiency of land ecosystems means we may see the amount of CO2 remaining in the atmosphere after fossil fuel burning and deforestation start to increase, shrinking the remaining carbon budget.

"What this means is that to avoid 1.5 or 2°C warming and the associated climate impacts, we need to adjust the remaining carbon budget to account for the weakening of the plant CO2 Fertilization Effect," he said. "And because of this weakening, land ecosystems will not be as reliable for climate mitigation in the coming decades."

Credit: 
NASA/Goddard Space Flight Center

Will we still need Covid-19 volunteers in the new year?

- A University of Sheffield-led research programme finds Local Authorities and the Voluntary and Community Sector are best placed to support the response to the Covid-19 crisis locally

Mobilising Volunteers Effectively found local initiatives are best placed to identify and mobilise volunteers

Thousands of members of the public have volunteered, helping their neighbours to stay fed, safe and connected

These volunteers will continue to play a central role during the festive period and into next year, as the socio-economic fallout of the pandemic continues to take hold

During the first national lockdown of the Covid-19 pandemic earlier this year, and subsequent social restrictions, thousands of volunteers provided a vital lifeline for many vulnerable people throughout an unprecedented time of anxiety and social restrictions.

Despite the launch of a new vaccination programme providing hope that the country is nearing the 'beginning of the end' of the health crisis, researchers from the Mobilising Volunteers Effectively (MoVE) project, warn that the socio-economic fallout from Covid-19 means that for many, the crisis is far from over, and that volunteers will continue to be one of many valuable assets needed during the challenging months ahead.

Dr Erica Ballantyne, co-investigator on the MoVE project from the University of Sheffield, said: "Providing access to food was identified as one of the first challenges in the early stages of the pandemic, which created demand for volunteers to aid the supply and distribution of essential food parcels, medication, other essential supplies and even befriending services for those socially isolated as a result of the pandemic.

"Whilst this demand has reduced, the longer-term issue of food poverty remains, which places increased pressure on the voluntary sector, particularly local food banks, who are called upon to provide continued support."

Dr Jon Burchell, Principal Investigator for the project from the University of Sheffield, said: "Whilst the rollout of vaccinations will hopefully lead to a gradual reduction in social restrictions, and thus a return to 'normal' for many, longer-term challenges, namely mental health and food poverty, have been exacerbated and show no signs of abating.

"The new year and the likely continuation of localised social restrictions, volunteers - both formal and informal - will continue to play a critical role in supporting our communities."

The third report of the MoVE project examined how local authorities (LAs) and their voluntary and community sector (VCS) partners worked together to identify and support those in need, reflecting on what can be learnt for the future as the crisis continues into 2021.

The research found that the national volunteering schemes that ran during the first lockdown (e.g. the NHS Volunteer Responders and Ready Scotland) may not have been the best way to achieve this.

LAs and the VCS organisations who participated in the study expressed frustration that they could not access these volunteers due to a lack of data sharing, and a general feeling that the resources channeled into these centralised platforms could have been more effectively utilised in supporting local responses.

Dr Erica Ballantyne, said: "Our research highlighted that a centralised service may not be able to understand and reflect the unique needs, assets and resources of different communities. This requires a flexible approach that links with local knowledge and infrastructure.

"The new report offers important insights around the value of informal, local volunteer responses and the principles of mutuality and reciprocity which underpin the most effective volunteering initiatives. Those organised by residents that lived in their community and were able to identify the appropriate responses for their community, whether that came from a good neighbour, a volunteer, or a VCS or LA service."

The findings are all the more significant, as it follows the recent publication of a UK Parliamentary report by Daniel Kruger MP: Levelling up our communities: proposals for a new social covenant commissioned by the Prime Minister.

This 'sets out a vision for a more local, more human, less bureaucratic, less centralised society', yet it continues to focus upon more centralised approaches to volunteering, encouraging all NHS Responders to sign up for a Volunteer Passport and carrying out a national communications campaign.

Volunteer-led community level responses will remain invaluable through the winter months, especially as social restrictions continue and the longer-term challenges of food poverty and social isolation remain. Meeting the needs of these groups will be all the more challenging given the crisis that the VCS is facing.

Professor Joanne Cook, from the University of Hull, said: "VCS capacity is being eroded by the resource squeeze, volunteers returning to work, and staff and volunteer fatigue. Ensuring the sector has the resources it requires to play its critical role in meeting community needs over the coming months, should be a key priority for local and national governments."

Credit: 
University of Sheffield

Recently discovered comet seen during 2020 total solar eclipse

image: (left) The LASCO C2 camera on the ESA/NASA SOHO observatory shows comet C/2020 X3 (SOHO) in the bottom left-hand corner. (right) A composite image of the total solar eclipse on Dec. 14, 2020, based on 65 frames taken by Andreas Möller (Arbeitskreis Meteore e.V.) in Piedras del Aguila, Argentina, and processed by Jay Pasachoff and Roman Vanur.

Image: 
ESA/NASA/SOHO/Andreas Möller (Arbeitskreis Meteore e.V.)/processed by Jay Pasachoff and Roman Vanur/Joy Ng. Eclipse image used with permission.

As Chile and Argentina witnessed the total solar eclipse on Dec. 14, 2020, unbeknownst to skywatchers, a little tiny speck was flying past the Sun -- a recently discovered comet.

This comet was first spotted in satellite data by Thai amateur astronomer Worachate Boonplod on the NASA-funded Sungrazer Project -- a citizen science project that invites anyone to search for and discover new comets in images from the joint European Space Agency (ESA) and NASA Solar and Heliospheric Observatory, or SOHO.

Boonplod discovered the comet on Dec. 13, the day before the eclipse. He knew the eclipse was coming, and was eager to see whether his new comet discovery might appear in the Sun's outer atmosphere as a small speck in eclipse photographs.

The comet, named C/2020 X3 (SOHO) by the Minor Planet Center, is a "Kreutz" sungrazer. This family of comets originated from a large parent comet that broke up into smaller fragments well over a thousand years ago and continues to orbit around the Sun today. Kreutz sungrazing comets are most commonly found in SOHO images. SOHO's camera works by mimicking total solar eclipses: A solid occulting disk blocks out the otherwise blinding light of the Sun, revealing dimmer features in its outer atmosphere and other celestial objects like comets. To date, 4,108 comets have been discovered in SOHO images, with this comet being the 3,524th Kreutz sungrazer spotted.

Around the time the eclipse image was taken, the comet was traveling at roughly 450,000 miles per hour, about 2.7 million miles from the Sun's surface. The comet was around 50 feet in diameter -- about the length of a semitruck. It then disintegrated to dust particles due to intense solar radiation, a few hours before reaching its closest point to the Sun.

Credit: 
NASA/Goddard Space Flight Center

Roadmap to renewables unites climate and sustainability goals

image: Great egrets sit atop a floatovoltaic array in Florida in 2020.

Image: 
Rebecca R. Hernandez, UC Davis

While the pressures of climate change bring a sense of urgency to renewable energy development, a new study serves as a roadmap toward uniting the goals of a low-carbon future with that of ecological sustainability and conservation.

The study, published in the journal Frontiers in Sustainability from the University of California, Davis, and John Hopkins University, aims to help decision-makers avoid the unintended environmental consequences of renewable energy development.

"Renewables aren't always sustainable, but they can be if we think proactively," said co-leading author Sarah Jordaan, an assistant professor at John Hopkins University's School of Advanced International Studies. "There is a huge misalignment between United Nations Sustainable Development Goals and climate goals. This is a call to action for leaders to come together to address it."

To develop the roadmap, the authors assessed public and private investments in renewable energy and analyzed the tradeoffs and synergies of clean energy. They also identified research themes drawn from a two-day workshop held by the Electric Power Research Institute in 2019 with 58 leading experts in the fields of renewable energy and sustainability from across academia, industry, government sectors.

MISSING THE FOREST FOR THE GHGs

Among the key research priorities identified for sustainable solar and wind developments include site selection and understanding interactions with wildlife.

For example, Florida's longleaf pine forests have, for centuries, helped store carbon, protect water quality and provide wildlife habitat. Now, only a fraction of the historical range of longleaf pine forests in the state remain. Yet a sliver of that remaining sliver is slated to be replaced by a solar installation.

Meanwhile, in the same state and just a few miles away, waterbirds squawk, preen their feathers, and hunt for food atop a floating array of solar panels - a "floatovoltaic" installation. Here, both wildlife and greenhouse-gas-reduction goals appear to coexist gracefully.

"We can't pursue climate change mitigation blindly," said co-leading author Rebecca. R. Hernandez, a UC Davis assistant professor and founding director of the Wild Energy Initiative in the John Muir Institute of the Environment. "We must consider the impacts of renewables on the few ecosystems we have left."

Other key considerations and priorities the scientists identified were public acceptance of clean energy projects and the study of end-of-life management for wind and solar. For instance, the composites in wind blades are not recyclable, and solar panels contribute to a growing electronic waste problem.

PUSHING FORWARD

The authors said the work highlights how the field of sustainable renewable energy is in its infancy, with many of the questions and solutions unclear. The roadmap, they emphasize, is a living document, designed to change as the field matures.

"We're pushing forward into maturation something that is really just being born," Hernandez said of renewable energy. "Across its sectors, everyone is trying to figure things out as quickly as possible. This roadmap points to the fact that we all need to get organized and work together to share knowledge, innovation and results."

Jordaan said while the roadmap highlights problems, they are solvable.

"We need to research the things we don't know, implement solutions we do know, and develop technology as needed and ensure accountability," she said.

Credit: 
University of California - Davis

Scientists get the most realistic view yet of a coronavirus spike's protein structure

image: This rotating image shows the detailed structure of a "spike" from a coronavirus that causes cold symptoms - a milder relative of the virus that causes COVID-19. Spikes bind to receptors on the cells of their victims to start infections. They consist of three protein molecules, shown in blue, green and orange, studded with sugar molecules (yellow) that play an important role in the virus's life cycle and in its ability to evade the immune system. Scientists at SLAC National Accelerator Laboratory and Stanford University made the image with a new method that shows spikes in their natural state, yielding quicker and more realistic snapshots of the infection apparatus.

Image: 
K. Zhang et al., Quarterly Reviews of Biophysics Discovery, 2020

Coronaviruses like the one that causes COVID-19 are studded with protein "spikes" that bind with receptors on the cells of their victims ­- the first step in infection. Now scientists have made the first detailed images of those spikes in their natural state, while still attached to the virus and without using chemical fixatives that might distort their shape.

They say their method, which combines cryogenic electron microscopy (cryo-EM) and computation, should produce quicker and more realistic snapshots of the infection apparatus in various strains of coronavirus, a critical step in designing therapeutic drugs and vaccines.

"The advantage of doing it this way is that when you purify a spike protein and study it in isolation, you lose important biological context: How does it look in an intact virus particle? It could possibly have a different structure there," said Wah Chiu, a professor at DOE's SLAC National Accelerator Laboratory and Stanford University and senior author of the study. They described their results in Quarterly Reviews Biophysics Discovery.

Seven strains of coronaviruses are known to infect humans. Four cause relatively mild illnesses; the other three - including SARS-CoV-2, the virus that causes COVID-19 - can be deadly, said co-author Jing Jin, an expert in the molecular biology of viruses at Vitalant Research Institute in San Francisco. Scientists at Vitalant hunt for viruses in blood and stool samples from humans and animals, screen blood samples during outbreaks like the current pandemic, and study interactions between viruses and their hosts.

The virus that causes COVID-19 is so virulent that there are only a few cryo-EM labs in the world that can study it with a high enough level of biosafety controls, Jin said. So for this study, the research team looked at a much milder coronavirus strain called NL63, which causes common cold symptoms and is responsible for about 10% of human respiratory disease each year. It's thought to attach to the same receptors on the surfaces of human cells as the COVID-19 virus does.

Rather than chemically removing and purifying NL63's spike proteins, the researchers flash-froze whole, intact viruses into a glassy state that preserves the natural arrangement of their components. Then they made thousands of detailed images of randomly oriented viruses using cryo-EM instruments at the Stanford-SLAC Cryo-EM Facilities, ­­­­digitally extracted the bits that contained spike proteins, and combined them to get high-resolution pictures.

"The structure we saw had exactly the same structure as it does on the virus surface, free of chemical artifacts," Jin said. "This had not been done before."

The team also identified places where sugar molecules attach to the spike protein in a process called glycosylation, which plays an important role in the virus's life cycle and in its ability to evade the immune system. Their map included three glycosylation sites that had been predicted but never directly seen before.

Although a German group has used a similar method to digitally extract images of the spike protein from SARS-CoV-2, Jin said, they had to fix the virus in formaldehyde first so there would be no danger of it infecting anyone, and this treatment may cause chemical changes that interfere with seeing the true structure.

Going forward, she said, the team would like to find out how the part of the spike that binds to receptors on human cells is activated, and also use the same technique to study spike proteins from the virus that causes COVID-19, which would require specialized biohazard containment facilities.

Credit: 
DOE/SLAC National Accelerator Laboratory

New study identifies greatest risk factors of mortality from COVID-19

Hospitalized COVID-19 patients have a greater risk of dying if they are men or if they are obese or have complications from diabetes or hypertension, according to a new study conducted by University of Maryland School of Medicine (UMSOM) researchers. In a study published in the journal Clinical Infectious Diseases, the researchers evaluated nearly 67,000 hospitalized COVID-19 patients in 613 hospitals across the country to determine the link between certain common patient characteristics and the risk of dying from COVID-19.

Their analysis found that men had a 30 percent higher risk of dying compared to women of the same age and health status. Hospitalized patients who were obese, had hypertension or poorly managed diabetes had a higher risk of dying compared to those who did not have these conditions. Those aged 20 to 39 with these conditions had the biggest difference in their risk of dying compared to their healthier peers.

"Predicting which hospitalized COVID-19 patients have the highest risk of dying has taken on urgent importance as cases and hospitalizations in the U.S. continue to surge to record high numbers during the month of December," said study corresponding author Anthony D. Harris, MD, MPH, Professor of Epidemiology and Public Health at UMSOM. "Knowledge is power in many ways, so I think understanding which hospitalized COVID-19 patients are at highest risk of mortality can help guide difficult treatment decisions."

For example, higher-risk patients may be given the drug remdesivir earlier in their hospitalization to help prevent severe complications or may be considered for closer monitoring or ICU admission. Healthcare providers may also want to consider these risks when determining which COVID-19 patients could benefit the most from the new monoclonal antibody therapies that, if given in the first few days of the infection, can reduce the risk of hospitalization.

Age remained the strongest predictor of mortality from COVID-19. Overall, nearly 19 percent of hospitalized COVID-19 patients died from their infection with the lowest mortality among pediatric patients, which was less than 2 percent. Mortality rates increased with each decade of life with the highest mortality, 34 percent, among those aged 80 and older.

"Older patients still have the highest risk of dying, but younger patients with obesity or hypertension have the highest risk of dying relative to other patients their age without these conditions," said study lead author Katherine E. Goodman, JD, PhD, a postdoctoral fellow in the Department of Epidemiology and Public Health at UMSOM. "Doctors may want to be paying extra attention to these younger patients when they're hospitalized to ensure they detect any complications quickly."

The researchers also found some good news in their study findings. Death rates among hospitalized patients have fallen dramatically since the early weeks of the pandemic in April. This is likely due to the availability of new treatments and more knowledge in the medical community on how to properly manage and care for hospitalized patients.

"As we head into what may be the darkest weeks of the pandemic, it is reassuring to know that our researchers are continuing to make important advances that could help guide the decision-making skills of healthcare workers in the field," said E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. "I am incredibly proud of our faculty and what they have accomplished to help save the lives of COVID-19 patients as we eagerly await a vaccine."

Credit: 
University of Maryland School of Medicine

Zika virus affects eye development before but not after birth

image: Cross-section of the eye of an infant rhesus monkey eye exposed to Zika virus in utero, showing an oval-shaped defect in the retina.

Image: 
Glenn Yiu and Koen Van Rompay, UC Davis

While the SARS-CoV-2 virus has dominated the news this past year, researchers continue to study the health effects of the Zika virus, which has been reported in 86 countries globally.

The Zika virus is primarily transmitted by the bite of an infected mosquito from the Aedes genus. However, it can also be passed through sexual contact, blood transfusions, organ transplants, and between mother and baby during pregnancy. The virus has been documented to cause a range of birth defects, including microcephaly and various neurological, musculoskeletal, and eye abnormalities.

A new study from Glenn Yiu, associate professor in the Department of Ophthalmology, and Koen Van Rompay, a core scientist at the California National Primate Research Center, found that Zika infection during the first trimester of pregnancy can impact fetal retinal development and cause congenital ocular anomalies. The virus does not appear to affect ocular growth postnatally, however.

"It has been known that congenital infection with the Zika virus can lead to eye defects, but it was unclear if the virus continues to replicate or affect eye development after birth," Yiu said. "Our study in rhesus monkeys suggest that the virus primarily affects fetal development during pregnancy, but not the growth of eye after birth."

In this collaboration between the UC Davis Eye Center and the California National Primate Research Center, two pregnant rhesus monkeys were infected with Zika virus late in the first trimester. The ocular development of the Zika-exposed infants was then studied for two years following their birth.

Ocular birth defects

The Zika-exposed infant monkeys did not display microcephaly or apparent neurological or behavioral deficits. The infants did exhibit several ocular birth defects, however. The defects included large colobomas, a missing gap in the eye due to abnormal development. The Zika-exposed infant monkeys also exhibited a loss of photoreceptors -- the light-sensing cells of the retina -- and retinal ganglion neuron, which helps transmit visual information to the brain.

Despite congenital ocular malformations at birth, their eyes appeared to follow normal development during their first two years.

The findings suggest that ocular defects due to Zika infection primarily occur in utero and likely do not have a continued impact on ocular development after birth.

Rhesus macaques are natural hosts of the virus and share similar immune and ocular characteristics to humans, including blood-retinal barrier characteristics and the unique presence of a macula, making them superior animal models of the infection than typical laboratory animals like mice and rats. The findings were published in JCI Insight, an open-access peer-reviewed journal dedicated to biomedical research.

Credit: 
University of California - Davis

Researchers propose process to detect and contain emerging diseases

FAYETTEVILLE, Ark. - A University of Arkansas biologist is part of a global team of researchers developing a strategy to detect and intercept diseases emerging from wildlife in Africa that could eventually infect humans.

Assistant professor Kristian Forbes, along with colleagues from Africa, Europe and North America, have proposed a four-part approach to detect and contain zoonotic diseases, those that begin in animals but spillover into humans, like COVID-19 and HIV.

"A lot of research effort to prepare against the threat of novel disease emergences of wildlife viruses has been to identify unknown viruses in wildlife that might someday infect humans," Forbes said. "These efforts have been very successful for identifying new viruses; indeed, thousands have been discovered, but we don't currently have the tools to know which of them pose the most immediate risks to human health."

To enable fast detection of new zoonotic disease outbreaks, the team proposes a system of procuring and screening samples from hospital patients with fevers of unknown origin, analyzing samples from suspicious fatalities of unknown cause, testing blood serum in high-risk or sentinel groups and analyzing samples that have already been collected and archived. The team outlined their approach in a recent article published in the journal The Lancet Microbe.

None of these methods are new, Forbes said. But to date they have not been combined into a continent-wide program aimed at rapid detection.

"Given limitations to the current model for preventing disease emergences, our article focuses on a coordinated and widespread strategy for early detection so that novel disease outbreaks can be intercepted before they potentially become global pandemics."

Credit: 
University of Arkansas

Ultra-fast gas flows through tiniest holes in 2D membranes

image: Researchers identify ultra-fast gas flows through atomic-scale apertures in 2D membrane and validate a century-old equation of fluid dynamics.

Image: 
N Hassani & M N-Amal, Shahid Rajee University

Researchers from the National Graphene Institute at the University of Manchester and the University of Pennsylvania have identified ultra-fast gas flows through the tiniest holes in one-atom-thin membranes, in a study published in Science Advances.

The work - alongside another study from Penn on the creation of such nano-porous membranes - holds promise for numerous application areas, from water and gas purification to monitoring of air quality and energy harvesting.

In the early 20th century, renowned Danish physicist Martin Knudsen formulated theories to describe gas flows. Emerging new systems of narrower pores challenged the Knudsen descriptions of gas flows, but they remained valid and it was unknown at which point of diminishing scale they might fail.

The Manchester team - led by Professor Radha Boya, in collaboration with the University of Pennsylvania team, led by Professor Marija Drndi? - has shown for the first time that Knudsen's description seems to hold true at the ultimate atomic limit.

The science of two dimensional (2D)-materials is progressing rapidly and it is now routine for researchers to make one-atom-thin membranes. Professor Drndi?'s group in Pennsylvania developed a method to drill holes, one atom wide, on a monolayer of tungsten disulphide. One important question remained, though: to check if the atomic-scale holes were through and conducting, without actually seeing them manually, one by one. The only way previously to confirm if the holes were present and of the intended size, was to inspect them in a high resolution electron microscope.

Professor Boya's team developed a technique to measure gas flows through atomic holes, and in turn use the flow as a tool to quantify the hole density. She said: "Although it is beyond doubt that seeing is believing, the science has been pretty much limited by being able to only seeing the atomic pores in a fancy microscope. Here we have devices through which we can not only measure gas flows, but also use the flows as a guide to estimate how many atomic holes were there in the membrane to start with."

J Thiruraman, the co-first author of the study, said: "Being able to reach that atomic scale experimentally, and to have the imaging of that structure with precision so you can be more confident it's a pore of that size and shape, was a challenge."

Professor Drndi? added: "There's a lot of device physics between finding something in a lab and creating a usable membrane. That came with the advancement of the technology as well as our own methodology, and what is novel here is to integrate this into a device that you can actually take out, transport across the ocean if you wish [to Manchester], and measure."

Dr Ashok Keerthi, another lead author from the Manchester team, said: "Manual inspection of the formation of atomic holes over large areas on a membrane is painstaking and probably impractical. Here we use a simple principle, the amount of the gas the membrane lets through is a measure of how holey it is."

The gas flows achieved are several orders of magnitude larger than previously observed flows in angstrom-scale pores in literature. A one-to-one correlation of atomic aperture densities by transmission electron microscopy imaging (measured locally) and from gas flows (measured on a large scale) was combined by this study and published by the team. S Dar, a co-author from Manchester added: "Surprisingly there is no/minimal energy barrier to the flow through such tiny holes."

Professor Boya added: "We now have a robust method for confirming the formation of atomic apertures over large areas using gas flows, which is an essential step for pursuing their prospective applications in various domains including molecular separation, sensing and monitoring of gases at ultra-low concentrations."

Credit: 
University of Pennsylvania

More than half of Hudson River tidal marshes were created accidentally by humans

image: The arrival of the railroad and associated structures in 1850 along the banks of New York's Hudson River Tidal Estuary in several areas created the conditions for marshes to form.

Image: 
courtesy of the Dams and Sediment in the Hudson project

AMHERST, Mass. - In a new study of tidal marsh resilience to sea level rise, geologist and first author Brian Yellen at the University of Massachusetts Amherst and colleagues observed that Hudson River Estuary marshes are growing upward at a rate two to three times faster than sea level rise, "suggesting that they should be resilient to accelerated sea level rise in the future," he says.

Writing in Earth Surface Processes and Landforms, Yellen and colleagues documented that more than half of Hudson River tidal marshes formed since 1850. That year, the channel was straightened and a riverside railroad, berms, jetties and human-made islands of dredged soil were built. This all trapped sediment and created backwaters that often - but not always - turned into marshes, an "unintended result of early industrial development," they state.

"In one case, historical aerial photos document this transition occurring in less than 18 years, offering a timeframe for marsh development," they point out. Yellen's co-authors are colleagues Jonathan Woodruff, Caroline Ladlow and undergraduate Waverly Lau at UMass Amherst, plus Sarah Fernald at New York's department of environmental conservation and David K. Ralston of Woods Hole Oceanographic Institution.

Yellen notes that for this "very collaborative" study, the researchers took advantage of "an experiment that has already happened over decades or centuries. Many of these accidental tidal marshes worked; they protect the shoreline and provide one of the richest ecosystems in terms of direct ecological and human benefits."

Further, marshes are "really useful," he adds - as a first line of defense against coastal flooding, essential habitat for juvenile commercial fish species, they store huge amounts of carbon that mitigates climate change, they provide habitat for migratory birds, filter nutrients coming off the land "and they're beautiful."

Yellen and colleagues write that these tidal wetlands "currently trap roughly 6% of the Hudson River's sediment load. Results indicate that when sediment is readily available, freshwater tidal wetlands can develop relatively rapidly in sheltered settings. The study sites serve as useful examples to help guide future tidal marsh creation and restoration efforts."

Their research involved seven sites spanning more than 100 miles of the Hudson Estuary, "from Wall Street up to Albany," Yellen says. The bays where tidal marshes developed started out six to seven feet deep and have steadily grown vertically. "One concern for marshes globally is that they will be drowned by rising sea level, but this case study shows how marshes can be created and it gave us some timing benchmarks for what is considered a tricky ecosystem restoration," he adds.

The researchers used two main methods to investigate the river's history and resilience in the face of sea level rise - sediment cores that shed light on how fast sediment accumulated and historical maps, charts and aerial photos to determine how the sites have changed over time.
Yellen summarizes, "As long as there is space for sediment to accumulate, new marshes can develop. There is a community of land trusts up and down the river who are planning now for future sea level rise and considering where new marshes can form. This research will help them and state agencies guide land acquisition and land conservation strategies adjacent to the river to 2100 and beyond."

The research, part of the Dams and Sediment in the Hudson (DaSH) project, was supported by a grant to Ralston from NOAA's National Estuarine Research Reserve Collaborative, plus the U.S. Geological Survey and the Department of Interior Northeast Climate Adaptation Science Center at UMass Amherst.

Also, Lau received a Polgar Fellowship from the Hudson River Foundation for her senior thesis project. She took the lead on one of the sites and made a short film about tidal marshes around the world and the Hudson River marsh near her home in Queens.

Credit: 
University of Massachusetts Amherst

Gene biomarkers indicate liver toxicity quickly and accurately

image: From left: University of Illinois researchers Zeynep Madak-Erdogan, associate professor of nutrition; Rohit Bhargava, director of the Cancer Center; and Colleen Bushell, director of the Healthcare Innovation Program Office at the National Center for Supercomputing Applications collaborated on a project to detect potential liver toxicity through genetic biomarker identification.

Image: 
University of Illinois.

URBANA, Ill. ¬- When agrochemical and pharmaceutical companies develop new products, they must test extensively for potential toxicity before obtaining regulatory approval. This testing usually involves lengthy and expensive animal studies.

A research team at University of Illinois has developed a gene biomarker identification technique that cuts the testing process down to a few days while maintaining a high level of accuracy.

"The aim of this research was to identify the smallest set of indicators from the liver to predict toxicity and potential liver cancer," says Zeynep Madak-Erdogan, associate professor in the Department of Food Science and Human Nutrition at U of I and a lead author on the study.

"The agrochemical industry has a pipeline where they test new compounds in terms of toxicity-related endpoints. Liver toxicity is one of the most important endpoints, because the liver is the organ that receives the blood supply and cleans it, making it one of the biggest targets in terms of environmental toxic action," Madak-Erdogan explains.

Normally, companies do this through long-term animal experiments, she adds. They track animals for up to a year to see if they develop liver cancer after exposure to these compounds. The studies require thousands of mice or rats, and a lot of human time taking care of the animals, collecting samples, and analyzing the data.

The study, published in Scientific Reports, identifies a biomarker gene signature that indicates potential liver toxicity just 24 hours after exposure.

Madak-Erdogan and her colleagues analyzed information from a large database maintained by the National Institute of Environmental Health Sciences. In collaboration with scientists at the U of I National Center for Supercomputing Applications (NCSA), they used machine learning approaches to identify gene biomarkers in messenger RNA to predict future toxicity.

"From designing new molecules to identifying novel biological targets, machine learning approaches are playing a key role in accelerating drug target identification and validation," explains Colleen Bushell, director of NCSA's Healthcare Innovation Program Office and co-author on the study.

While this study is not the first to employ such techniques, it is the most comprehensive, Madak-Erdogan says. The researchers used a large amount of data and multiple machine learning techniques in order to identify the methods that provide the fastest and most accurate results.

"We are assessing the best prediction techniques and finding the best indicators for liver toxicity. Instead of going for months or years, now we can just treat a few mice for 24 hours, collect livers, look at the biomarkers we identified, and predict whether the animal will potentially develop liver cancer or not," she explains.

The study's results can be used broadly by toxicologists and other scientists, and can help the agrochemical and pharmaceutical industry improve their testing capabilities.

"Our findings show machine learning approaches are definitely very valuable in analyzing the vast amount of biological data that we create in our research activities. Collaboration between life sciences and computer sciences is very important for this work," Madak-Erdogan concludes.

Credit: 
University of Illinois College of Agricultural, Consumer and Environmental Sciences